BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22045824)

  • 1. Evaluation of the nationwide cervical screening programme in Thailand: a case-control study.
    Kasinpila C; Promthet S; Vatanasapt P; Sasieni P; Parkin DM
    J Med Screen; 2011; 18(3):147-53. PubMed ID: 22045824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of cytology-based cervical cancer screening in the Colombian health system].
    Murillo R; Cendales R; Wiesner C; Piñeros M; Tovar S
    Biomedica; 2009 Sep; 29(3):354-61. PubMed ID: 20436987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
    Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
    Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case-control study of the effectiveness of mass screening in reducing invasive cervical cancer].
    Makino H; Sato S; Yajima A; Fukao A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1226-32. PubMed ID: 1919184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic study of risk factors in cancer of the cervix uteri in Thai women.
    Punyaratabandhu P; Supanvanich S; Tirapat C; Podhipak A
    J Med Assoc Thai; 1982 May; 65(5):231-9. PubMed ID: 7119622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA; Shittu SO; Randawa JA; Shehu MS
    Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with cervical cancer: why did screening not prevent these cases?
    de Bie RP; Vergers-Spooren HC; Massuger LF; Siebers AG; Salet-van der Pol MR; Vedder JE; Melchers WJ; Bulten J; Bekkers RL
    Am J Obstet Gynecol; 2011 Jul; 205(1):64.e1-7. PubMed ID: 21481838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.